insights_auto
Why is CUV down 2.84%?
Dive Deeperchevron_right
CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7.52
arrow_downward
-2.84%(-0.22) 1D
Nov 6, 4:10:28 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$8.30
High
A$8.30
Low
A$7.39
Mkt. cap
379.66M
Avg. vol.
157.70K
Volume
172.46K
Dividend
0.66%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.26
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
Open
A$8.30
High
A$8.30
Low
A$7.39
Mkt. cap
379.66M
Avg. vol.
157.70K
Volume
172.46K
Dividend
0.66%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.26
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
News stories
From web sources and news partners
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteclinuvel.com